Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart DRC | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$1.06T | 41.7x | 97.47 | CA$41.79 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Loblaw Companies | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$66.07B | 30.4x | 4.44 | CA$221.42 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.1% Upside | Upgrade to Pro+ | |
George Weston | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$34.42B | 30x | -3.88 | CA$266.97 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.1% Upside | Upgrade to Pro+ | |
George Weston Ser 3 Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$34.42B | 30x | -3.88 | CA$22.66 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston 5.20 Ser Iv Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$34.42B | 30x | -3.88 | CA$22.66 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston 4.75 Ser V Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$34.42B | 30x | CA$21.99 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
George Weston | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$34.42B | 30x | CA$266.81 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
George Weston Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$34.42B | 30x | -3.88 | CA$24.87 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Metro Inc. | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$22.72B | 23.2x | 6.11 | CA$103.63 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1% Downside | Upgrade to Pro+ | |
Empire Company | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$11.90B | 18.2x | -2.57 | CA$51.28 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.6% Downside | Upgrade to Pro+ | |
North West | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$2.60B | 19x | 3.32 | CA$54.36 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.8% Upside | Upgrade to Pro+ | |
Green Thumb | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$1.70B | 26.8x | -1.99 | CA$7.17 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Glass House Brands | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$344.21M | -56.2x | -0.61 | CA$7.74 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
High Tide | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$260.62M | -40.3x | -0.45 | CA$3.23 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Verano Holdings | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$255.40M | -0.7x | 0 | CA$0.70 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CareRx | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$178.33M | -47.2x | -7.01 | CA$2.83 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 37.9% Upside | Upgrade to Pro+ | |
Terrascend | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$135.47M | -1.4x | -0.1 | CA$0.38 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Planet 13 Holdings | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$89.96M | -1.5x | -0.03 | CA$0.28 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Colabor Group Inc. | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$87.73M | -86x | 1.14 | CA$0.86 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Two Hands | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$69.47M | -3.9x | -0.19 | CA$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Two Hands | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$69.47M | -3.9x | -0.19 | CA$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaCorp Rx | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$56.49M | -91.3x | -1.12 | CA$0.50 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marimed | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$37.78M | -1.8x | -0.43 | CA$0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MariMed | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$37.78M | -1.8x | -0.45 | CA$0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DAVIDsTEA | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$28.45M | -8.8x | -0.11 | CA$1.04 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
C21 Invest | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$23.57M | CA$0.20 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Gold Flora | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$14.96M | -0.1x | 0 | CA$0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nass Valley Gateway | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$11.62M | -7.5x | CA$0.04 | -12.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Im Cannabis | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$10.72M | -1.9x | -0.08 | CA$5.10 | -40% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CordovaCann | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$9M | -11.3x | -0.12 | CA$0.06 | -7.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CLS Holdings USA | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$8.12M | 8.7x | 0.13 | CA$0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Blueberries Medical | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$7.43M | -2.4x | -0.12 | CA$0.01 | 50% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ayurcann Holdings | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$4.87M | -1.6x | -0.05 | CA$0.03 | -16.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rocky Mountain Liquor | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$4.78M | -2.5x | 0 | CA$0.10 | 5.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ORAGIN Foods | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$3.12M | -1x | CA$0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Astron Connect | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$605.42K | -8.1x | -0.12 | CA$0.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vegano Foods | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$440.10K | CA$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Kiaro Holdings | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$221.07K | -0x | CA$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |